Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Enhanced regimen is a specific preoperative antibiotic prophylaxis protocol developed by Mansoura University for patients undergoing retrograde intrarenal surgery (RIRS) who are at high risk for infectious complications. The regimen consists of a short-course (2-day) administration of antibiotics, primarily utilizing sulfamethoxazole-trimethoprim (TMP-SMX) twice daily, with the final dose administered one day prior to surgery. In instances of patient allergy or bacterial resistance, the protocol allows for the use of nitrofurantoin, ciprofloxacin, or cefpodoxime as alternatives. This regimen is currently being evaluated in a Phase 3 randomized controlled trial against an Extended regimen (7-day course) to determine its efficacy in preventing postoperative urosepsis and other infections while potentially reducing overall antibiotic exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enhanced regimen (Mansoura University).